Raras
Buscar doenças, sintomas, genes...
Calcifilaxia
ORPHA:280062CID-10 · E83.5CID-11 · EB90.42DOENÇA RARA

A calcifilaxia é uma doença na qual os vasos sanguíneos (veias e artérias) ficam bloqueados por um acúmulo de cálcio nas paredes dos vasos, impedindo que o sangue flua para a pele ou órgãos internos. A falta de fluxo sanguíneo (isquemia) danifica o tecido saudável e causa sua morte (necrose). O sintoma mais óbvio e frequente da calcifilaxia são os danos à pele, pois as úlceras podem se desenvolver e infeccionar facilmente. A calcifilaxia também pode afetar o tecido adiposo, os órgãos internos e o músculo esquelético, causando infecções, dor e falência de órgãos. Esses sintomas costumam ser irreversíveis e muitos indivíduos com calcifilaxia podem não sobreviver mais do que alguns meses após serem diagnosticados devido a uma infecção que se espalha por todo o corpo (sepse) ou falência de órgãos. A causa exata da calcifilaxia é desconhecida. Os tratamentos podem incluir medicamentos para reduzir a dor, antibióticos para tratar infecções e várias abordagens para prevenir o desenvolvimento ou agravamento desta condição.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A calcifilaxia é uma doença na qual os vasos sanguíneos (veias e artérias) ficam bloqueados por um acúmulo de cálcio nas paredes dos vasos, impedindo que o sangue flua para a pele ou órgãos internos. A falta de fluxo sanguíneo (isquemia) danifica o tecido saudável e causa sua morte (necrose). O sintoma mais óbvio e frequente da calcifilaxia são os danos à pele, pois as úlceras podem se desenvolver e infeccionar facilmente. A calcifilaxia também pode afetar o tecido adiposo, os órgãos internos e o músculo esquelético, causando infecções, dor e falência de órgãos. Esses sintomas costumam ser irreversíveis e muitos indivíduos com calcifilaxia podem não sobreviver mais do que alguns meses após serem diagnosticados devido a uma infecção que se espalha por todo o corpo (sepse) ou falência de órgãos. A causa exata da calcifilaxia é desconhecida. Os tratamentos podem incluir medicamentos para reduzir a dor, antibióticos para tratar infecções e várias abordagens para prevenir o desenvolvimento ou agravamento desta condição.

Pesquisas ativas
7 ensaios
21 total registrados no ClinicalTrials.gov
Publicações científicas
1.765 artigos
Último publicado: 2026 Mar 16

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adult
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E83.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
2 sintomas
📏
Crescimento
1 sintomas
🫘
Rins
1 sintomas

+ 9 sintomas em outras categorias

Características mais comuns

90%prev.
Hiperparatireoidismo secundário
Muito frequente (99-80%)
90%prev.
Cutis marmorata
Muito frequente (99-80%)
90%prev.
Doença renal crônica estágio 5
Muito frequente (99-80%)
90%prev.
Celulite
Muito frequente (99-80%)
90%prev.
Úlcera cutânea
Muito frequente (99-80%)
90%prev.
Calcificação arterial
Muito frequente (99-80%)
13sintomas
Muito frequente (12)
Frequente (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 13 características clínicas mais associadas, ordenadas por frequência.

Hiperparatireoidismo secundárioSecondary hyperparathyroidism
Muito frequente (99-80%)90%
Cutis marmorata
Muito frequente (99-80%)90%
Doença renal crônica estágio 5Stage 5 chronic kidney disease
Muito frequente (99-80%)90%
CeluliteCellulitis
Muito frequente (99-80%)90%
Úlcera cutâneaSkin ulcer
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.765PubMed
Últimos 10 anos200publicações
Pico202590 papers
Linha do tempo
2026Hoje · 2026🧪 2005Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 34
2Fase 21
1Fase 13
·Pré-clínico11
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Calcifilaxia

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

6 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

21 ensaios clínicos encontrados, 7 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
874 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 874

#1

Resolution of penile calciphylaxis in a high-risk dialysis patient with medical therapy and wound care.

BMJ case reports2026 Feb 05

Penile calciphylaxis is a rare but life-threatening manifestation of calcific uraemic arteriolopathy, most often seen in patients with end-stage renal disease (ESRD) on dialysis. Its diagnosis is frequently delayed, and its presence carries a poor overall prognosis. Given its rarity, treatment strategies and their efficacy have been understudied and may include observation, medical therapy, radical surgery or hyperbaric oxygen therapy. In this case, we describe a patient with ESRD presenting with a rapidly progressive penile lesion ultimately diagnosed as penile calciphylaxis. Our patient was ineligible for hyperbaric oxygen therapy and declined surgical management. Consequently, unlike many reported cases requiring surgical management nonetheless resulting in poor outcomes, our patient experienced lesional resolution with conservative therapy, specifically intravenous sodium thiosulfate and structured wound care with medical-grade honey, within 9 months after presentation. This case highlights a novel non-surgical approach to a difficult clinical situation and shows the potential efficacy and novelty of non-surgical management in select patients where penile calciphylaxis is diagnosed early in its course.

#2

Lived experiences of patients with calciphylaxis (CALCI-E): a qualitative study.

Journal of nephrology2026 Mar 16

Calciphylaxis is a rare, severe condition, mainly affecting people undergoing dialysis. It occurs when small arterioles within the skin become calcified causing painful skin lesions. There are currently no diagnostic tests or licensed treatments. This qualitative study explored patient experiences to identify opportunities to improve diagnosis and management of this challenging condition. Participants were recruited between October 2023 and December 2024. A sample of 10-20 people was sought. Participants were eligible to take part if they lived in England or Wales and were over 18 years of age, had capacity to consent, and had a current or previous (<3 years) diagnosis of calciphylaxis, or were a caregiver (or relative) of someone with calciphylaxis. Interviews were recorded, transcribed and anonymised, and analysed using inductive, reflexive thematic analysis. Seventeen participants were recruited (14 patients, median age 68 years, 43% male; 3 relatives). Six overarching themes were identified. 1 Diagnostic Delays and Awareness Gaps; symptoms were often dismissed; 2 Pain and Symptom Experience; pain was frequently poorly managed; 3 Treatment and Medication Burden; severe side effects and very limited treatment explanation; 4 Wound Care Variability; often negative experiences and inconsistent practices; 5 Support and Psychological Impact; lack of emotional and practical support; 6 Patient Recommendations; better communication, education, and knowledge sharing. This first in-depth thematic analysis of the experiences of patients who developed calciphylaxis identified key priorities: improved patient/clinician education, better pain and wound management, and enhanced psychosocial and peer support. These findings should inform clinical pathways, educational tools, and support services, with further co-produced research to assess their impact. The study highlights the value of the patients' voices, their willingness to engage, and the need for patient experience measures in calciphylaxis and other rare diseases.

#3

[Challenges of ongoing VKA use in calciphylaxis: The potential of multimodal treatment including rheopheresis, — a case report].

Nephrologie &amp; therapeutique2026 Mar 10

We report two cases of complete remission of uremic calciphylaxis in hemodialysis patients despite continued use of vitamin K antagonists (VKAs). These cases highlight the potential of a multimodal treatment approach including rheopheresis as a promising therapy when VKA discontinuation is not feasible. Both patients presented with severe calciphylaxis while on VKAs for mechanical mitral valve replacement. They received intensive multimodal treatment, including daily hemodialysis, intravenous sodium thiosulfate, calcimimetics, phosphate binders, opioid analgesics, and plastic surgery evaluation. In addition, rheopheresis was initiated twice weekly for four months, during which VKAs were maintained. Rheopheresis frequency was then gradually reduced. Complete wound healing was achieved within seven months. Both patients subsequently underwent parathyroidectomy for tertiary hyperparathyroidism. To our knowledge, these are the first reported cases of full remission of calciphylaxis without VKA discontinuation. A multimodal, multidisciplinary treatment strategy may represent an effective approach for high-risk anticoagulated patients. Nous rapportons deux cas de rémission complète de calciphylaxie urémique chez des patients hémodialysés chroniques, malgré la poursuite d’un traitement par antivitamines K (AVK). Ces cas soulignent l’intérêt d’un traitement multimodal, incluant la rhéophérèse comme thérapie prometteuse lorsque l’arrêt des AVK est impossible. Les deux patients ont présenté une calciphylaxie urémique sévère sous AVK en raison d’une valve mécanique mitrale. Ils ont bénéficié d’un traitement multimodal intensif, incluant une hémodialyse quotidienne, du thiosulfate de sodium intraveineux, des calcimimétiques, des chélateurs du phosphate, des analgésiques opioïdes et une évaluation en chirurgie plastique. Un traitement par rhéophérèse a été initié deux fois par semaine pendant quatre mois, période pendant laquelle les AVK ont été maintenus. La fréquence des séances de rhéophérèse a ensuite été progressivement réduite. La guérison complète des plaies a été obtenue en sept mois. Les deux patients ont ensuite bénéficié d’une parathyroïdectomie devant une hyperparathyroïdie tertiaire. À notre connaissance, il s’agit des premiers cas rapportés de rémission complète de calciphylaxie urémique sans interruption des AVK. Cette stratégie de traitement multimodal et multidisciplinaire pourrait représenter une approche efficace chez les patients anticoagulés à haut risque.

#4

Wound Management and Surgery for Calcific Uremic Arteriolopathy (Calciphylaxis): A Retrospective Observational Cohort Study.

International wound journal2026 Mar

Wound care in calciphylaxis remains poorly defined without evidence-based consensus on timing and technique of surgical intervention. We demonstrate that surgical debridement and subsequent wound closure are safe and effective in calciphylaxis and describe a systematic multidisciplinary approach to intervention. We retrospectively reviewed a cohort of patients with calciphylaxis at our institution. Those who underwent surgical debridement and wound closure were analysed with emphasis on wound healing, progression to amputation and mortality. Sixty-two patients with calciphylaxis underwent surgical debridement. Twenty patients had wound closure by skin grafting, five were excised with primary wound closure, and 37 were debrided and allowed to heal by secondary intention. There were excellent rates of healing in all groups, and no patients demonstrated wound progression or new lesions following operative intervention. Surgical debridement and wound closure are safe and effective in treating wounds related to calciphylaxis.

#5

Postparathyroidectomy calciphylaxis in a patient with primary hyperparathyroidism: a rare complication.

JCEM case reports2026 Mar

Calciphylaxis, a rare and life-threatening condition involving calcification of small to medium-sized arterioles in subcutaneous tissue, leads to ischemia and necrosis. While typically seen in chronic kidney disease (CKD), a small proportion of cases can present without CKD, referred to as nonuremic calciphylaxis (NUC). NUC associated with primary hyperparathyroidism is rare with limited evidence-based management. A 41-year-old woman with no prior medical history presented with cardiac arrest due to severe hypercalcemia of 17.87 mg/dL (4.46 mmol/L) (normal reference range, 8.6-10.3 mg/dL; 2.2-2.6 mmol/L) and markedly elevated parathyroid hormone (PTH) levels. She required intensive care and extracorporeal membrane oxygenation (ECMO). Following stabilization, she underwent emergency parathyroidectomy for a parathyroid adenoma. During her prolonged recovery over 100 days, she developed painful necrotic skin lesions. Histopathology confirmed calciphylaxis. Management was conservative, involving wound care and analgesia, without surgical debridement. Her skin lesions resolved, and she has remained free of recurrence with stable calcium and PTH levels for more than 10 years. NUC following parathyroidectomy for primary hyperparathyroidism is rare. Multifactorial causes could contribute to the pathogenesis of calciphylaxis in our case, involving acute kidney injury, ECMO, and prolonged immobility. Early recognition and multidisciplinary management are crucial given the high mortality rate in calciphylaxis.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.355 artigos no totalmostrando 195

2026

Lived experiences of patients with calciphylaxis (CALCI-E): a qualitative study.

Journal of nephrology
2026

Hyperbaric oxygen treatment as a therapeutic option for penile calciphylaxis.

Asian journal of urology
2026

[Challenges of ongoing VKA use in calciphylaxis: The potential of multimodal treatment including rheopheresis, — a case report].

Nephrologie &amp; therapeutique
2026

Wound Management and Surgery for Calcific Uremic Arteriolopathy (Calciphylaxis): A Retrospective Observational Cohort Study.

International wound journal
2026

Postparathyroidectomy calciphylaxis in a patient with primary hyperparathyroidism: a rare complication.

JCEM case reports
2026

An Atypical Presentation of Cutaneous Angiosarcoma: A Diagnostic Challenge in an End-Stage Renal Disease Patient.

Cureus
2026

Diffuse Dermal Angiomatosis of the Breast Presenting as Diffuse Erythema Mimicking Inflammatory Breast Carcinoma in a Healthy Pregnant Patient.

The American Journal of dermatopathology
2026

Resolution of penile calciphylaxis in a high-risk dialysis patient with medical therapy and wound care.

BMJ case reports
2026

Amputation and reamputation for dry gangrene of both lower extremities in with chronic kidney disease patients with calciphylaxis accompanied by multidrug-resistant bacterial infections: A case report and literature analysis.

Medicine
2026

Ocular Calciphylaxis in a 46-year-old Man on Hemodialysis.

Ophthalmology
2025

Benign but bizarre: A case report on idiopathic scrotal calcinosis.

International journal of surgery case reports
2026

Calciphylaxis in a patient with end-stage renal disease: Multimodality imaging and clinical correlation.

Radiology case reports
2025

Atypical Calciphylaxis Following Parathyroidectomy and Persistent Severe Hypocalcemia in a Hemodialysis Patient: A Case Report.

Cureus
2025

Calciphylaxis in the Upper GI Tract in an ESRD Patient: An Atypical Presentation and Review of Literature.

Case reports in nephrology
2025

Idiopathic Penile Calcinosis Cutis: A Histopathological Case Report.

Reports (MDPI)
2025

Calcific Uremic Panniculitis: A Rare Form of Calciphylaxis in an Endstage Renal Disease Patient.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
2025

Navigating Calciphylaxis in End-Stage Renal Disease: A Case Report Highlighting the Complexities of Pain Control and the Need for Greater Clinical Vigilance.

Cureus
2025

Critical Limb Ischaemia in a Patient With Subcutaneous Nodules: Clues to a Hidden Systemic Disease.

Cureus
2025

The Skin: A Critical Window into Chronic Kidney Disease and a Call for Collaborative Care.

Journal of multidisciplinary healthcare
2025

Paradoxical effects of parathyroidectomy and sodium thiosulfate in a hemodialysis patient with calciphylaxis: a case report of persistent metastatic calcification.

Frontiers in medicine
2025

Calciphylaxis diagnosis, management and future directions: a comprehensive update on behalf of the European Renal Association CKD-MBD Working Group.

Clinical kidney journal
2026

Progressive painful skin lesions in a patient with end-stage renal disease.

JAAD case reports
2025

Multi-site Calciphylaxis With Pulmonary Calcification in a Young Haemodialysis Patient.

Cureus
2026

Skin Disorders in Kidney Disease: Core Curriculum 2026.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2025

Calciphylaxis Raising Suspicion for Factitious Dermatitis: A Diagnostic Challenge.

Cureus
2025

A study of three cases of acquired reactive perforating collagenosis mimicking calciphylaxis.

BMC nephrology
2025

Managing anticoagulation in a patient with Calciphylaxis and mechanical valve: a therapeutic dilemma.

Oxford medical case reports
2025

A case of penile calciphylaxis development shortly after initiation of dialysis for graft dysfunction following living donor kidney transplantation: a case report.

BMC nephrology
2025

A Case Report of Non-Uremic Calciphylaxis Refractory to Treatment Requiring Multidisciplinary Care.

Case reports in dermatology
2025

Pharmacological targeting of the IL-17/neutrophil axis attenuates calcific deposits in rat models of calciphylaxis.

The Journal of clinical investigation
2025

Systematic review of penile glans necrosis.

The journal of sexual medicine
2025

A Composite Dermal Matrix Comprising Ovine Forestomach Matrix and Hyaluronic Acid in the Treatment of Chronic Wounds Secondary to Calciphylaxis: A Case Series and Literature Review.

Advances in skin &amp; wound care
2025

Nonuremic penile calciphylaxis treated with pentoxifylline.

JAAD case reports
2025

Surgical Approach in the Treatment of Calciphylaxis: A Case Report.

Healthcare (Basel, Switzerland)
2025

Rituximab-induced nonuremic calciphylaxis in hairy cell leukemia: a singular case.

Italian journal of dermatology and venereology
2025

Penile Calciphylaxis: A Rare and Life-Threatening Condition.

Indian journal of nephrology
2025

Elevated Perioperative Morbidity After Parathyroidectomy for Calciphylaxis Patients: A Nationwide Retrospective Observational Study.

The Journal of surgical research
2025

A Case Report of Calciphylaxis.

Journal of education &amp; teaching in emergency medicine
2025

Penile Calciphylaxis: Two Clinical Cases and a Literature Review.

Cureus
2025

Aiming for calciphylaxis prophylaxis.

Journal of the American Academy of Dermatology
2025

Penile calciphylaxis: surgical management in the setting of Fournier's gangrene-a case report and literature review.

Translational andrology and urology
2025

A Novel FNDC1-NAMPT-NAD axis is Implicated in Small and Large-vessel Arterial Disease and Drives Vascular Calcification.

bioRxiv : the preprint server for biology
2025

The CALCIPHYX trial and its impact on calciphylaxis treatment: what's next?

Clinical kidney journal
2025

Warfarin Induced Non-Uremic Calciphylaxis.

Journal of Brown hospital medicine
2025

Navigating the patient-provider relationship during severe illness with lessons from a qualitative perspective of calciphylaxis.

Scientific reports
2025

Ten tips on how to deal with calciphylaxis patients.

Clinical kidney journal
2025

Chronic leg ulcers in a patient with Hyperoxaluria type 1: a rare and challenging diagnosis.

Oxford medical case reports
2025

Pathophysiology of Wound Development and Chronicity in Renal Disease: A Narrative Review.

International wound journal
2024

Buprenorphine for the Management of Intractable Pain in Skin Ulcers Associated With Calcific Uremic Arteriolopathy.

Pain medicine case reports
2025

Intralesional sodium thiosulfate is an effective treatment for nonuraemic calciphylaxis.

Clinical and experimental dermatology
2025

Calciphylaxis: A Mimic of Vasculitis.

Mediterranean journal of rheumatology
2025

Calciphylaxis: A Rare Manifestation of a Common Disease.

Cureus
2025

Part II. Dermatologic Manifestations Associated with Treatment of Patients with Kidney Disease.

Journal of the American Academy of Dermatology
2025

[Translated article] Multicenter retrospective analysis of sodium thiosulfate as treatment for non-uremic calciphylaxis.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
2025

Calciphylaxis in End-Stage Renal Disease: A Case of Nonhealing Ulcer and Diagnostic Challenges.

Cureus
2025

Treatment effects of human amnion-derived mesenchymal stem cells for skin lesions and metastatic pulmonary calcification in calciphylaxis patients - case series and literature review.

Renal failure
2025

Calciphylaxis following liver transplantation in a patient with end-stage renal disease: A case report.

World journal of radiology
2025

Penile Abscess Complicating Chronic Penile Calciphylaxis in a Heart Transplant Recipient and End-Stage Renal Disease Patient.

Cureus
2025

Calcinosis Cutis With Selective Fibroblast Growth Factor Receptor Inhibitors: A Case Report and Review of Literature.

Cureus
2025

Calcific uremic arteriolopathy with penile involvement post-kidney transplant.

Urology case reports
2025

IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxis.

Nature reviews. Nephrology
2025

Extensive Visceral Calciphylaxis in a Patient with End-stage Renal Disease: A Postmortem Revelation.

Internal medicine (Tokyo, Japan)
2025

Cutaneous cytomegalovirus in mixed serostatus kidney transplant patient.

SAGE open medical case reports
2026

Clinical Features and Treatment Outcomes of Cutaneous Calciphylaxis in Paediatric Patients: A Systematic Review.

Journal of cutaneous medicine and surgery
2025

Histologic comparison of normal and diseased skin in patients with suspected calciphylaxis.

Journal of the American Academy of Dermatology
2025

Outcomes and mortality in calciphylaxis: A multicenter update.

Journal of the American Academy of Dermatology
2025

Kidney transplantation and hyperbaric oxygen treatment for calciphylaxis.

Kidney international
2025

Calciphylaxis Triggered by Acute Kidney Injury and Malignancy: A Successfully Treated Case.

The Journal of dermatology
2025

Topical timolol for calciphylaxis: a case report.

Wounds : a compendium of clinical research and practice
2025

Calciphylaxis of the Upper Limbs-A Rare and Serious Disease with Multidisciplinary Treatments-A Case Series and Literature Review.

Diagnostics (Basel, Switzerland)
2025

Calciphylaxis in the Setting of Acute Kidney Injury.

Cureus
2025

Direct immunofluorescence testing for panniculitis offers negligible diagnostic utility: A retrospective single-center cohort study of 87 specimens.

Journal of the American Academy of Dermatology
2025

Acute Visual Loss and Mesenteric Nodules: Two Case Reports of Atypical Presentations of Calciphylaxis.

Case reports in nephrology and dialysis
2025

Hexasodium Fytate (SNF472 or CSL525) Inhibits Ectopic Calcification in Various Pseudoxanthoma Elasticum and Calcinosis Cutis Animal Models.

Pharmaceuticals (Basel, Switzerland)
2025

Activation and targetability of TYMP-IL-6-TF signaling in the skin microenvironment in uremic calciphylaxis.

Science translational medicine
2025

Calciphylaxis Penile Lesion: An Unusual Complication of End-Stage Renal Disease.

Cureus
2025

Autologous platelet-rich plasma therapy for skin ulceration due to calcific uremic arteriopathy: a case report and review of the literature.

International urology and nephrology
2025

Multicenter Evaluation of Certainty and Reliability in Calciphylaxis Diagnosis Using a Digital Imaging Platform.

Laboratory investigation; a journal of technical methods and pathology
2025

Calcific Uremic Arteriolopathy in Hemodialysis Patients: A Report of Two Cases and Review of the Literature.

Cureus
2025

Calciphylaxis Following Parathyroidectomy in Chronic Kidney Disease Patients-Case Report and Literature Review.

Biomedicines
2025

Corrigendum for the article Clin Nephrol. 2025; 103: 1-4.

Clinical nephrology
2025

Calciphylaxis: ongoing challenges and treatment opportunities with mesenchymal stem cells.

Journal of molecular cell biology
2025

A Case Report of Futibatinib-Induced Calciphylaxis.

Kansas journal of medicine
2025

Getting Crunchy With COVID-19: A Unique Case of Catastrophic Multiorgan Calciphylaxis.

The American journal of forensic medicine and pathology
2025

Nonbacterial Thrombotic Endocarditis of a Mitral Prosthesis After Warfarin, Enoxaparin, and Apixaban Failure.

JACC. Case reports
2025

Calciphylaxis in a Middle-Aged Asian Patient: An Unusual Cause of Disc Swelling.

Neuro-ophthalmology (Aeolus Press)
2025

A Rare Case of Calciphylaxis: A Case Report.

Biomedicine hub
2025

Imaging Features of Calciphylaxis on Conventional Radiography and Computerized Tomography.

Journal of the Belgian Society of Radiology
2025

Non-uremic calciphylaxis: A dermatologic complication in both MASH and alcohol-associated cirrhosis.

Clinical nephrology. Case studies
2025

Successful Management of Calciphylaxis with Sodium Thiosulfate in End-Stage Renal Disease: A Case Report.

Healthcare (Basel, Switzerland)
2025

Calciphylaxis in the absence of pathological skin lesions.

BMJ case reports
2025

Calciphylaxis: Beating the Odds.

Cureus
2025

A case of non-uremic calciphylaxis in a patient with secondary hyperparathyroidism and panhypopituitarism.

The Journal of dermatology
2025

Uremic Leontiasis Ossea due to Resistant Secondary Hyperparathyroidism.

AACE clinical case reports
2025

Myosin Heavy Chain Myopathy and Immune-Mediated Muscle Disorders.

The Veterinary clinics of North America. Equine practice
2025

Livedoid vasculopathy, calciphylaxis, and Martorell's hypertensive ulcer: update on ischemic ulcers due to impaired microcirculation of the lower limbs.

Anais brasileiros de dermatologia
2025

Sodium Thiosulfate Treatment for Calciphylaxis: Is There an Optimal Duration of Therapy?

Hemodialysis international. International Symposium on Home Hemodialysis
2025

Managing Calciphylaxis: Insights from Real-World Cases at a Tertiary Academic Center.

Advances in skin &amp; wound care
2025

Calciphylaxis in Coexistent Primary and Secondary Hyperparathyroidism.

Journal of clinical rheumatology : practical reports on rheumatic &amp; musculoskeletal diseases
2024

Risk Factors Associated With the Development of Calciphylaxis in Patients With Chronic Kidney Disease: A Systematic Review.

Cureus
2024

Sodium Thiosulfate: An Innovative Multi-Target Repurposed Treatment Strategy for Late-Onset Alzheimer's Disease.

Pharmaceuticals (Basel, Switzerland)
2025

Characteristics and prognostic values of abdominal aortic branches calcification in hemodialysis patients.

Renal failure
2024

Calciphylaxis: A Case Report and Review of the Role of Sodium Thiosulphate and Other Treatment Modalities.

Cureus
2025

Course and treatment of severe osteoporosis complicated by calciphylaxis: a case report.

JBMR plus
2024

Calcific Uremic Arteriolopathy (CUA) Among Malaysian Dialysis Patients: Clinical Characteristics, Treatment, and Outcomes.

Cureus
2024

Anticoagulant-associated calciphylaxis: analysis of USFDA adverse event report system and clinical feature analysis of reported cases.

Expert opinion on drug safety
2024

Outcomes in an educational skin-model session on point-of-care ultrasound for diagnosing calciphylaxis.

Skin health and disease
2024

Calciphylaxis in a Patient on Hemodialysis: A Case Report.

Cureus
2024

Hyperbaric oxygen therapy enables pain reduction and healing in painful chronic wounds, including in calciphylaxis.

Annales de dermatologie et de venereologie
2024

Redefining Calciphylaxis as a Uniquely Bone Forming Subcutaneous C5b-9-Mediated Microvascular Injury Syndrome Associated With Localized Subcutaneous and Systemic Complement Pathway Activation.

The American Journal of dermatopathology
2025

Hyperbaric oxygen treatment in addition to conventional multidisciplinary care in patients with calciphylaxis.

Clinical nephrology
2025

Gastrointestinal calciphylaxis: a rare and devastating complication in end-stage kidney disease.

CEN case reports
2024

A case of rapidly progressive unilateral non-nephrogenic hemorrhagic bullous calciphylaxis responding to systemic sodium thiosulfate therapy.

Wounds : a compendium of clinical research and practice
2024

Calciphylaxis Mimicking Giant Cell Arteritis: A Case Report.

Case reports in ophthalmology
2024

Penile Calciphylaxis: A Rare-Case Report of Calcific Uremic Arteriolopathy in a Patient with End-Stage Renal Disease and Severe Vascular Insufficiency.

Cureus
2024

Relapsing Calciphylaxis of the Breast: Glucocorticoids - Friend or Foe?

Indian journal of nephrology
2024

[Endogenous skin overloads].

Annales de pathologie
2024

Calciphylaxis and metastatic calcification.

Journal of nephrology
2024

Inositol Hexaphosphate in Bone Health and Disease.

Biomolecules
2024

Surgical Management of Penile Calciphylaxis Without Penectomy.

Cureus
2024

Penile Calciphylaxis Obscured by Phimosis in an End-Stage Renal Disease Patient: A Case Report.

Cureus
2024

Calciphylaxis in a 30-Year-Old Woman With Alcoholic Cirrhosis: A Case Report.

Cureus
2024

Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension.

EClinicalMedicine
2024

Advanced Calciphylaxis in a Patient With End-Stage Renal Disease: A Case Report Highlighting Diagnostic and Therapeutic Challenges in Late-Stage Presentation.

Cureus
2024

Individualizing the lifesaving journey for calciphylaxis: addressing rapidly progressive attacks with multidimensional and AI research for regenerative medicine.

Renal failure
2024

Updated solution for diagnosis and management of calcinosis cutis: A retrospective review.

Medicine
2024

Intravenous treatment of calcinosis cutis with sodium thiosulfate - A case series.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2024

The Differential Diagnosis of Leg Ulcers.

Deutsches Arzteblatt international
2024

The Relevance of Phytate for the Treatment of Chronic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN
2024

Emerging Indications for Hyperbaric Oxygen Treatment: Registry Cohort Study.

Interactive journal of medical research
2024

A Rare Case of Calcinosis Cutis Presenting to a Tertiary Care Hospital in Rural Maharashtra.

Cureus
2024

Assessment of diagnostic delay, morbidity, and mortality outcomes in 302 calciphylaxis patients over a 17-year period: A retrospective cohort study.

Journal of the American Academy of Dermatology
2024

Sodium thiosulfate: A donor or carrier signaling molecule for hydrogen sulfide?

Nitric oxide : biology and chemistry
2024

Non-chronic kidney disease-induced calciphylaxis: a rare case report.

Journal of surgical case reports
2024

Calciphylaxis Episodes in the Australia and New Zealand Dialysis and Transplant Registry.

Kidney international reports
2024

The Accelerated Onset of Calciphylaxis in a 72-Year-Old Female Hemodialysis Patient.

Cureus
2024

[Calciphylaxis, risk factors, treatment and outcomes. Retrospective study of 39 patients].

Medicina
2024

Evaluating the role of bone scan in diagnosing calciphylaxis in practice-A retrospective case series of patients who were clinically managed for calciphylaxis despite resulting negative on initial biopsy.

The Australasian journal of dermatology
2024

Calciphylaxis and Intractable Pain in a Veteran with Psychological Trauma History.

Journal of palliative medicine
2024

[The highlights of dialysis in 2023].

Nephrologie &amp; therapeutique
2024

Potential Role of Bone Scintigraphy in the Diagnosis of Calciphylaxis.

World journal of nuclear medicine
2024

Aluminium in dermatology - Inside story of an innocuous metal.

Indian journal of dermatology, venereology and leprology
2024

New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease.

Current opinion in nephrology and hypertension
2024

Progression of Skin Ulcer Secondary to Calciphylaxis in a Patient With End-Stage Renal Disease (ESRD) on Hemodialysis and the Therapeutic Approach.

Cureus
2024

Penile Calciphylaxis: A Successfully Treated Case.

Cureus
2024

Histopathology and radiologic imaging for the confirmation of calciphylaxis in a diverse population: A retrospective cohort study.

Journal of the American Academy of Dermatology
2024

SNF472: a novel therapeutic agent for vascular calcification and calciphylaxis.

Journal of nephrology
2024

Successful treatment of non-uremic calciphylaxis with combination therapy with sodium thiosulfate, iloprost, and heparin.

International journal of dermatology
2024

Management and mechanism of calciphylaxis in a patient treated with the FGFR inhibitor pemigatinib-a case report.

Journal of gastrointestinal oncology
2024

Nonuremic Calciphylaxis: A Rare and Unexpected Diagnosis of Necrotic Ulcers.

Journal of the American Podiatric Medical Association
2024

Calciphylaxis in POEMS syndrome: Case report.

Rare (Amsterdam, Netherlands)
2024

A Peculiar Presentation of a Debilitating Condition: Calciphylaxis.

Cureus
2024

Inflammatory and vaso-occlusive ulcers: Part I - Clinical presentation and diagnosis.

Journal of the American Academy of Dermatology
2024

Evaluation of the histopathological spectrum of skin biopsies in patients with chronic kidney disease: A single-center experience.

Indian journal of pathology &amp; microbiology
2024

Prevalence and risk factors for development of recurrent calciphylaxis.

Journal of the American Academy of Dermatology
2024

Occlusive cutaneous vasculopathies as cause of chronic ulcers.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2024

Coexistence of nephrogenic systemic fibrosis and calciphylaxis in a gadolinium-naïve, chronic haemodialysis patient.

BMJ case reports
2024

Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience.

Renal failure
2023

Calciphylaxis, beware the ophthalmic mimic: A case series.

Clinical nephrology. Case studies
2024

Images in Vascular Medicine: Nonuremic calciphylaxis secondary to occult malignancy.

Vascular medicine (London, England)
2023

Calciphylaxis in a Patient With Lupus Nephritis and Acute Kidney Injury: A Rare Case Report and Literature Review.

Journal of investigative medicine high impact case reports
2023

Repeat, Bilateral Femoral Nerve Blocks With Liposomal Bupivacaine for Analgesia in a Patient With Calciphylaxis: A Case Report.

A&amp;A practice
2023

Calciphylaxis in a patient with hypoparathyroidism and MEN-1 syndrome.

Endocrinology, diabetes &amp; metabolism case reports
2023

Calciphylaxis: An Unusual and Silent Usher for an Underlying Carcinoma.

Cureus
2023

Intralesional Sodium Thiosulfate as Adjuvant Therapy in Severe Calciphylaxis.

Journal of drugs in dermatology : JDD
2023

Calcific Uremic Arteriolopathy in End-Stage Renal Disease: A Rare Life-Threatening Condition.

Cureus
2024

Role of bone scan in diagnosis of calciphylaxis: A review.

JAAD international
2023

Surgical management of pain or infection secondary to calciphylaxis: a wound center's experience and algorithmic multidisciplinary approach.

Wounds : a compendium of clinical research and practice
2024

Intralesional sodium thiosulfate for the treatment of calciphylaxis: a case report and review of the literature.

International journal of dermatology
2023

Uremic Bilateral Breast Calciphylaxis: A Case Report and Literature Review.

Cureus
2023

Calciphylaxis: A Rare Complication With a Fatal Outcome in End-Stage Renal Disease.

Cureus
2023

Black necrosis of the glans penis associated with calciphylaxis: A case report.

Medicine
2023

Scrotal calciphylaxis in a fifty-one-year-old man with end-stage renal disease and prior bacteremia.

Urology case reports
2023

Calciphylaxis during the course of psoriatic arthritis patient. Is it coincidence? A case report.

Annals of medicine and surgery (2012)
2023

Calciphylaxis Secondary to Vitamin D Supplementation.

Cureus
2023

Sailing between scylla and charybdis-anticoagulation dilemma in a patient with calciphylaxis and mechanical cardiac valve replacement: a case report and literature review.

Renal failure
2023

Early diagnosis strategy of calciphylaxis in dialysis patients.

Renal failure
2023

Risk factors, treatment modalities, and clinical outcomes of penile calciphylaxis: systematic review.

World journal of urology
2023

Penile Calciphylaxis - A Rare, Yet Medically Treatable Disease.

Indian journal of nephrology
2023

Clinical management of nonuremic calcific arteriolopathy: a report of three cases.

Wounds : a compendium of clinical research and practice
2023

Influence of sodium thiosulfate on coronary artery calcification of patients on dialysis: a meta-analysis.

Renal failure
2023

Elastic fiber alterations and calcifications in calcific uremic arteriolopathy.

Scientific reports
2023

Multimodality approach to treat calciphylaxis in end-stage kidney disease patients.

Renal failure
2023

Non-uremic Calciphylaxis With Possible Initial Misdiagnosis as Erythema Multiforme/Toxic Epidermal Necrolysis Successfully Treated as Inpatient.

Cureus
2023

Penile calciphylaxis, infrequent complication with bad prognosis: a case report.

Urology case reports
2023

Differential diagnosis of stage 2, 3 and 4 pressure injuries of the pelvis and lower extremity: a case series.

Journal of wound care
2023

Distinguishing dystrophic calcification from calciphylaxis.

JAAD case reports
2023

A Rare Case of Post-parathyroidectomy Calciphylaxis in a Young Patient With End-Stage Renal Disease: A Case Report and Literature Review.

Cureus
2024

A retrospective review of outcomes after hyperbaric oxygen therapy for the treatment of calciphylaxis.

Journal of the American Academy of Dermatology
2023

Sodium Thiosulfate for Calciphylaxis Treatment in Patients on Peritoneal Dialysis: A Systematic Review.

Medicina (Kaunas, Lithuania)
2023

Phosphate Toxicity and Vascular Calcification in Chronic Kidney Disease: A Closer Look Utilizing Transmission Electron Microscopy.

Current protein &amp; peptide science
2024

Nephrogenic Calciphylaxis Arising after Bariatric Surgery: A Case Series.

American journal of nephrology
2023

Cutaneous vascular calcifications in patients with chronic kidney disease and calcific uremic arteriolopathy: a cross-sectional study.

Journal of nephrology
2023

[A Case of Penile Calciphylaxis in a Hemodialysis Patient].

Hinyokika kiyo. Acta urologica Japonica
2023

A case of nonuremic calciphylaxis of the penis responding to sodium thiosulfate therapy.

JAAD case reports
Ver todos os 1.355 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Calcifilaxia.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Calcifilaxia

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Resolution of penile calciphylaxis in a high-risk dialysis patient with medical therapy and wound care.
    BMJ case reports· 2026· PMID 41644201mais citado
  2. Lived experiences of patients with calciphylaxis (CALCI-E): a qualitative study.
    Journal of nephrology· 2026· PMID 41837776mais citado
  3. [Challenges of ongoing VKA use in calciphylaxis: The potential of multimodal treatment including rheopheresis, &#x2014; a case report].
    Nephrologie &amp; therapeutique· 2026· PMID 41805282mais citado
  4. Wound Management and Surgery for Calcific Uremic Arteriolopathy (Calciphylaxis): A Retrospective Observational Cohort Study.
    International wound journal· 2026· PMID 41760579mais citado
  5. Postparathyroidectomy calciphylaxis in a patient with primary hyperparathyroidism: a rare complication.
    JCEM case reports· 2026· PMID 41743175mais citado
  6. Hyperbaric oxygen treatment as a therapeutic option for penile calciphylaxis.
    Asian J Urol· 2026· PMID 41815374recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:280062(Orphanet)
  2. MONDO:0017215(MONDO)
  3. GARD:5980(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Artigo Wikipedia(Wikipedia)
  6. Q1026326(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Calcifilaxia
Compêndio · Raras BR

Calcifilaxia

ORPHA:280062 · MONDO:0017215
Prevalência
Unknown
Herança
Not applicable
CID-10
E83.5 · Distúrbios do metabolismo do cálcio
CID-11
Ensaios
7 ativos
Início
Adult
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0006666
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades